Gauging the pharmaceutical burden on Sydney’s environment: a preventative response

Abstract Metabolized and/or unmetabolized fractions of pharmaceuticals upon excretion or being washed from the skin can undergo complex chemical reactions. Entering the sewerage system some may also react with other synthetic chemicals to form unfathomable brews. Unfortunately most sewerage treatment plants fail to remove a sizeable proportion of these compounds. Their impact when released to the environment as a component of treated effluent remains a matter for conjecture although some insight has, for example, derived from work done on the effects of antibiotics on insects at entry points (dung) to pasture and groundwater. There is the possibility too that effects are occurring toward the limits of detection of suspect compounds notably endocrine disruption. To draw attention to the seriousness of the local problem in a situation where no data exists, a gross estimate of the annual drug load has been made for Sydney’s environment using statistics collected under the Australian Government’s Prescribed Benefits and Repatriation Benefits Scheme. This amounts to 17 tonnes but allowing for hospitals and clinics as well as OTC and illicit drugs, the overall figure is probably closer to 30 tonnes per annum. A two-prong impact reduction strategy is proposed comprising suggestions for curbing the discharge of existing medications and most importantly, a longer term fix utilising both natural product pharmaceuticals and vaccines and even gene therapy.

[1]  P. Barnes,et al.  Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial , 2002, European Respiratory Journal.

[2]  C. Tzen,et al.  Regulation of differentiation, proliferation and cancer suppressor activity. , 1993, The International journal of developmental biology.

[3]  K. Kümmerer Pharmaceuticals in the Environment , 2001 .

[4]  John Jensen,et al.  Veterinary Medicines and Soil Quality: The Danish Situation as an Example , 2001 .

[5]  Christian G. Daughton,et al.  Illicit Drugs in Municipal Sewage: Proposed New Nonintrusive Tool to Heighten Public Awareness of Societal Use of Illicit-Abused Drugs and Their Potential for Ecological Consequences , 2001 .

[6]  John P. Sumpter,et al.  Long-Term Temporal Changes in the Estrogenic Composition of Treated Sewage Effluent and Its Biological Effects on Fish , 2000 .

[7]  K. Bjerve,et al.  Omega 3 fatty acid deficiency in man: implications for the requirement of alpha-linolenic acid and long-chain omega 3 fatty acids. , 1991, World review of nutrition and dietetics.

[8]  Alfredo C. Alder,et al.  Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater , 1998 .

[9]  Christian G. Daughton,et al.  Pharmaceuticals and Care Products in the Environment: Scientific and Regulatory Issues , 2001 .

[10]  Ettore Zuccato,et al.  Environmental Loads and Detection of Pharmaceuticals in Italy , 2001 .

[11]  W. H. Betts,et al.  Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel , 1997, InflammoPharmacology.

[12]  Ungemach Fr,et al.  Figures on quantities of antibacterials used for different purposes in the EU countries and interpretation. , 2000 .

[13]  G. Burr,et al.  ON THE NATURE AND RÔLE OF THE FATTY ACIDS ESSENTIAL IN NUTRITION , 1930 .

[14]  Thomas Ternes,et al.  Pharmaceuticals and Metabolites as Contaminants of the Aquatic Environment , 2001 .